Table 2.
Therapeutic approaches and outcomes in patients treated with curative intent (N = 10).
| Treatment or outcome, No of patients (%) | Data value |
|---|---|
|
| |
| Induction chemotherapy | 2 (20) |
| Radiation therapy | 10 (100) |
| Definitive RT | 9 (90) |
| Adjuvant RT | 1 (10) |
| Definitive RT, median dose Gy (range) | 72.0 (66.0–76.4) |
| Concomitant chemotherapy | 7 (70) |
| Cisplatin and etoposide | 4 (57) |
| Carboplatin and paclitaxel | 1 (14) |
| Cisplatin only | 2 (28) |
| Surgery, No (%) | 3 (30) |
| Up-front surgery | 1 (33) |
| Salvage surgery | 2 (67) |
|
| |
| Best response to definitive (chemo)radiation | |
| CR | 7 (78) |
| PD | 1 (11) |
| Unknown | 1 (11) |
| Recurrence | 8 (80) |
| Median DFS (95% CI), mo | 13.1 (8.53-NA) |
CR, complete response; DFS, disease-free survival; PD, progressive disease.